MENU
NMRA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Neumora Therapeutics (NMRA) Earnings Date & Reports

Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed... Show more

A.I. Advisor
published Earnings

NMRA is expected to report earnings to fall 17.39% to -18 cents per share on November 05

Neumora Therapeutics NMRA Stock Earnings Reports
Q3'26
Est.
$-0.19
Q2'26
Beat
by $0.04
Q1'26
Est.
$-0.30
Q4'25
Beat
by $0.12
Q3'25
Beat
by $0.10
The last earnings report on August 14 showed earnings per share of -23 cents, beating the estimate of -27 cents. With 2.64M shares outstanding, the current market capitalization sits at 93.14M.